Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.9%

5 terminated/withdrawn out of 170 trials

Success Rate

95.2%

+8.7% vs industry average

Late-Stage Pipeline

28%

48 trials in Phase 3/4

Results Transparency

12%

12 of 99 completed trials have results

Key Signals

7 recruiting12 with results

Enrollment Performance

Analytics

N/A

50(41.0%)

Phase 4

28(23.0%)

Phase 3

20(16.4%)

Phase 2

13(10.7%)

Phase 1

11(9.0%)

122Total

N/A(50)

Phase 4(28)

Phase 3(20)

Phase 2(13)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (170)

Showing 20 of 170 trials

NCT02433795Phase 2Completed

Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)

Role: collaborator

NCT05514405Not ApplicableRecruiting

Effect of Remimazolam and Propofol on Postoperative Delirium

Role: lead

NCT07318428Not ApplicableEnrolling By Invitation

AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and Glaucoma

Role: lead

NCT06086665Completed

The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer

Role: collaborator

NCT07091773Not ApplicableNot Yet Recruiting

A Clinical Trial to Evaluate the Safety and Effectiveness of OLIZ, a Photobiomodulation Medical Device for Surgical Site Pain Relief in Patients After Total Knee Arthroplasty

Role: collaborator

NCT05439057Not ApplicableCompleted

Effect of Remimazolam on Postoperative Nausea and Vomiting

Role: lead

NCT04738786Not ApplicableTerminated

Clinical Study Evaluating the Proper Surgical Safety Margin for Early Stage Oral Tongue Cancers

Role: collaborator

NCT03130452Phase 4Completed

Helicobacter Pylori Eradication Study

Role: lead

NCT06329141Phase 2Recruiting

A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Role: collaborator

NCT02673424Not ApplicableUnknown

Fractional FLow Reserve And IVUS for Clinical OUtcomes in Patients With InteRmediate Stenosis

Role: collaborator

NCT05770687Recruiting

SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study

Role: collaborator

NCT03791788Completed

Multicenter Registry for Angiography-Derived Quantitative Flow Ratio

Role: collaborator

NCT02715518Not ApplicableCompleted

FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease

Role: collaborator

NCT06104033Recruiting

Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease

Role: collaborator

NCT01873560Completed

Influence of FFR on the Clinical Outcome After Percutaneous Coronary Intervention

Role: lead

NCT05636189Not ApplicableCompleted

Effect of Prewarming During Induction of General Anesthesia Combined With Warmed Intravenous Fluid on Core Temperature.

Role: lead

NCT05280886Unknown

Multi-site Cohort Study for the Development of Personalized Pharmacotherapy in Patients With Tuberculosis (TB)

Role: lead

NCT05766644Not ApplicableUnknown

App-based Education Program for CKD

Role: lead

NCT04991272Not ApplicableCompleted

10 Minutes Prewarming and Warmed Intravenous Fluid on Core Temperature

Role: lead

NCT03524508Phase 2Completed

Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer

Role: collaborator